In collaboration with Professor Zhang Jianquan of the Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen IUOC will help the scientific research of COPD
Shenzhen IUOC and Professor Zhang Jianquan from the Department of Respiratory and Critical Care Medicine of the Eighth Affiliated Hospital of Sun Yat-sen University signed a medical research agreement on "effective mechanism of iuo products for COPD"
In order to promote early diagnosis and treatment of COPD, Shenzhen IUOC. (hereinafter referred to as "IUOC intelligence") and Professor Zhang signed a research agreement on May 6, 2021,jointly launching the "clinical research project on the effect of IUOC electric heating pipe on the quality of life and lung function of tobacco addicted COPD patients".
Mr. Guo Hongli, founder of IUOC intelligence, and Professor Zhang Jianquan, and other relevant people attended the launching ceremony.
Protect the health of smokers, technology changes life
Founded in 2017, IUOC intelligence is a high-tech company integrating R & D, production and sales of various innovative products. Since its establishment, IUOC intelligence has been adhering to the concept of "protect the health of smokers and change life with technology".
It has continuously launched ordinary-cigarette-heating products that can effectively reduce the harm of smoking. The company successively obtained 26 patents (up to 2021, a total of 46 patents), making it one of the top 10 enterprises in China applying for heat- not-burn technology.
The object of this research is IUO electric heating pipe, which is a new high-tech auxiliary tool for reducing harm of smoking.It's developed by IUOC intelligence. The core patent technology is "external segmented ring heating", which can bake out nicotine and aroma in traditional cigarettes, and effectively reduce the content of tar (the main carcinogen of cigarettes) and other harmful substances.According to the test result of ICAS in Shanghai ,IUOC electric heating pipe can reduce 95% of the harmful substances in the smoke, and is suitable for all brands of traditional cigarettes on the market.It also restores the taste of cigarettes.
Since the launch of the product, IUOC intelligence has frequently received feedback from users, saying that their lung health has improved. Some users suspected that they had reversed from severe COPD to mild after persisting in using the product for half a year.In response to this phenomenon, Mr. Guo Hongli, the founder of IUOC intelligence, decided to start the research with Professor Zhang Jianquan to provide data support for the research on "earlier diagnosis and treatment of COPD".
The study of effective mechanism is of great significance
Chronic obstructive pulmonary disease (COPD) is often referred to as chronic bronchitis and emphysema.The prevalence rate of COPD in China is high and the base is large. TThe Lancet, an international authoritative medical journal, has published a research report that the total prevalence rate of COPD in Chinese adults is 8.6%, which means that there are about 100 million COPD patients in China.It has become the third largest killer after cerebrovascular and ischemic heart diseases. People over 40 years old are more prone to COPD. As a chronic respiratory disease, long-term smoking is an important cause of COPD.
Professor Zhang Jianquan also said that COPD has the characteristics of high morbidity, high disability rate,high case-fatality rate and high disease burden. Long disease cycle, repeated acute exacerbations and a variety of complications of COPD also seriously affect the prognosis and quality of life of patients.
The company and Professor Zhang agree to conduct a prospective, randomized controlled clinical study. This is of great significance for the prevention and standardized management of COPD, and also provides a useful reference for the global prevention and treatment of COPD.
It is said that "the medical research on the effective mechanism of IUOC products on COPD" starts with Internet of Things, big data and other new technologies.They are seeking
100 tobacco addicted COPD patients to carry out an 18-month medical test and clinically study whether IUO can improve the quality of life and lung function of COPD patients.Besides,they want to test whether it can reduce the airway inflammation and peripheral blood inflammation of COPD patients.
IUOC Intelligence helps smokers around the world stay healthy
There are many difficulties in the treatment of COPD.Zhong Nanshan, academician of the Chinese Academy of Engineering and winner of the medal of the People's Republic of China, once pointed out that chronic COPD is an important research direction for him. "Nearly 40 years,many new drugs have been developed for chronic obstructive pulmonary disease, however,they just alleviate the airway obstruction of patients slightly. Early intervention, early detection and early treatment are extremely important for this kind of chronic diseases."
Academician Zhong's point of view coincides with the original intention of IUOC intelligence.The company hopes to thoroughly analyze the effective mechanism of IUOC products in the project and apply the result of research to product development, so as to effectively promote the scientific prevention and treatment of COPD.
It is said IUOC intelligence is currently making every effort to promote the organic combination of advanced technology and health.It is combining R & D,design and medical area and creating a worldwide marketing network.The object of IUOC is to be
a "high-tech assistant" in the field of medical and health and help the scientific transformation and upgrading of China's medical industry,and further more,provide a "solution" for the global health of smokers.
Contact Person: James
Tel: +86135 3820 9999